News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Truitt Joseph
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/18/2023 |
4
| Truitt Joseph (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 2,750 shares
@ $3.73, valued at
$10.3k
|
|
| 05/11/2023 |
4
| Truitt Joseph (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $5.09, valued at
$42.2k
|
|
| 05/12/2022 |
4
| Truitt Joseph (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $2.92, valued at
$24.2k
|
|
| 05/20/2021 |
4
| Truitt Joseph (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $10.34, valued at
$85.8k
|
|
| 12/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2020 |
4/A
| Truitt Joseph (CEO) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 100,000 options to buy
@ $63.72, valued at
$6.4M
|
|
| 09/30/2020 |
4
| Truitt Joseph (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 16,600 options to buy
@ $11.9, valued at
$197.5k
|
|
| 06/05/2020 |
3
| Truitt Joseph (Director) has filed a Form 3 on Larimar Therapeutics, Inc. |
| 05/29/2020 |
4
| Truitt Joseph (CEO) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 130,000 options to buy
@ $63.72, valued at
$8.3M
|
|
| 04/15/2020 |
3
| Truitt Joseph (See Remarks) has filed a Form 3 on BIOSPECIFICS TECHNOLOGIES CORP |
| 01/29/2020 |
4
| Truitt Joseph (CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Disposed/sold 3,500 shares
@ $6.3, valued at
$22.1k
Disposed/sold 142,000 options to buy
@ $7.61, valued at
$1.1M
Disposed/sold 100,000 options to buy
@ $7.59, valued at
$759k
Disposed/sold 185,000 options to buy
@ $4.11, valued at
$760.4k
Disposed/sold 632,000 options to buy
@ $3.78, valued at
$2.4M
Disposed/sold 30,000 options to buy
@ $3.66, valued at
$109.8k
Disposed/sold 87,766 options to buy
@ $3.1, valued at
$272.1k
Disposed/sold 200,000 options to buy
@ $3.02, valued at
$604k
Disposed/sold 419,000 options to buy
@ $2.9, valued at
$1.2M
Disposed/sold 1,097,000 options to buy
@ $2.18, valued at
$2.4M
|
|
| 10/18/2019 |
4
| Truitt Joseph (CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 100,234 shares
@ $6.3749, valued at
$639k
Sold 33,250 shares
@ $6.3749, valued at
$212k
Exercised 33,250 options to buy
@ $3.28, valued at
$109.1k
Exercised 100,234 options to buy
@ $3.1, valued at
$310.7k
|
|
| 01/25/2019 |
4
| Truitt Joseph (CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 1,097,000 options to buy
@ $2.18, valued at
$2.4M
|
|
| 05/03/2018 |
4
| Truitt Joseph (CEO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 632,000 options to buy
@ $3.78, valued at
$2.4M
|
|
| 02/13/2018 |
4
| Truitt Joseph (Chief Commercial Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 419,000 options to buy
@ $2.9, valued at
$1.2M
|
|
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/22/2016 |
4
| Truitt Joseph (Chief Commercial Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 142,000 options to buy
@ $7.61, valued at
$1.1M
|
|
| 12/04/2014 |
4
| Truitt Joseph (EVP, Chief Commercial Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 110,000 options to buy
@ $13.24, valued at
$1.5M
|
|
| 08/26/2014 |
4
| Truitt Joseph (EVP, Chief Commercial Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 25,000 shares
@ $10.82, valued at
$270.5k
Exercised 25,000 options to buy
@ $0.82, valued at
$20.5k
|
|
| 06/17/2014 |
4
| Truitt Joseph (EVP, Chief Commercial Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 25,000 shares
@ $7.82, valued at
$195.5k
Exercised 25,000 options to buy
@ $0.82, valued at
$20.5k
|
|
| 06/11/2014 |
4
| Truitt Joseph (EVP, Chief Commercial Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 1,050 shares
@ $4.82, valued at
$5.1k
Sold 48,950 shares
@ $6.05, valued at
$296.1k
Exercised 1,050 options to buy
@ $0.82, valued at
$861
Exercised 48,950 options to buy
@ $0.82, valued at
$40.1k
|
|
| 03/06/2014 |
4
| Truitt Joseph (EVP, Chief Commercial Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $3.66, valued at
$109.8k
|
|
| 12/19/2013 |
4
| Truitt Joseph (SVP, Chief Commercial Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 200,000 options to buy
@ $3.02, valued at
$604k
|
|
| 12/20/2012 |
4
| Truitt Joseph (SVP, Chief Commercial Officer) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 145,000 options to buy
@ $8.64, valued at
$1.3M
|
|
| 12/14/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/20/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|